Alpha Teknova, Inc.TKNO

NasdaqHealthcareIn Vitro & In Vivo Diagnostic Substances
Price (close)
$9.29
Market cap
$498.7M
P/E
—
Revenue (TTM)
$43.7M
Net income
-$16.8M
Dividend yield
—
1-year total return
60.4%
Net margin
-38.4%
Revenue growth
12.3%
Debt / equity
0.21x

What Alpha Teknova, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$31.3M$36.9M$41.4M$36.7M$37.7M$40.5M
Net income$3.6M-$9.8M-$47.5M-$36.8M-$26.7M-$17.3M
Free cash flow-$3.0M-$28.9M-$55.5M-$26.7M-$13.5M-$9.8M

More on TKNO.

Figures from Alpha Teknova, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.